Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

American College of Lifestyle Medicine announces certification of TrueNorth Health Center, a medically supervised, water-only fasting facility to address chronic disease

Leave a comment


For nearly 40 years, TrueNorth Health Center has helped more than 20,000 people regain their health. The Center, located in Santa Rosa, California, was founded in 1984 by Drs. Alan Goldhamer and Jennifer Marano to teach patients healthful living practices. This involved encouraging an exclusively whole plant food diet without the addition of SOS (salt, oil and sugar), as well as respecting the need for sleep and exercise. The approach they established offers participants the opportunity to obtain evaluation and treatment for a wide variety of problems.

The staff at TrueNorth Health Center includes physicians, chiropractors, naturopaths, psychologists, research scientists and other health professionals. They have extensive experience in the evaluation and conservative management of high blood pressure, diabetes, autoimmune disorders and a wide range of other health conditions. The Center is now the largest residential facility in the world that specializes in medically supervised, water-only fasting.

Participants come to the Center to fast and heal, lose weight, and make diet and lifestyle changes while enjoying a health-promoting diet derived from whole natural foods. It is a unique place to rest, to rejuvenate, and to learn to achieve optimum health.

The long-term health benefits of water-only fasting are often dependent on dietary and lifestyle modifications. In order to facilitate these changes, TrueNorth offers extensive educational programs dealing with diet, food preparation, exercise, proper body use, stress management, sleep, and psychology. These programs are presented in the form of audio and videotapes, live lectures, demonstrations, question-and-answer sessions, and individual consultations. Meals are prepared from fresh fruits and vegetables grown in the Center’s own organic gardens whenever possible.

The ACLM program certification designation is based on evidence including data on program outcomes.

“ACLM is proud to recognize TrueNorth Health Center as a certified lifestyle medicine program,” said ACLM President Beth Frates, MD, DipABLM, FACLM. “Its residential, intensive lifestyle medicine program has been shown to help thousands truly change their lifestyle and the course of their disease.”

True North is the sixth program to earn certification designation from ACLM. The others are: Pivio (formerly the Complete Health Improvement Program), Chanwuyi Lifestyle Medicine Program, The Lift Project, Rochester Lifestyle Medicine Institute’s 15-Day WFPB Jumpstart and Full Plate Living.

ABOUT ACLM–The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management.

Media Contact

Jean Tips, American College of Lifestyle Medicine, 19719835383, [email protected], www.lifestylemedicine.org

SOURCE American College of Lifestyle Medicine

Health

Seeing the Unseen in the Tumor Microenvironment, Upcoming Webinar Hosted by Xtalks

Leave a comment


In this webinar, the featured speaker will review representative multiplexed assays for protein and RNA profiling that have been built in the lab and will discuss the necessary elements to operationalize this type of testing in a translational research laboratory. He will also explore the advantages of different types of assays and key considerations for ensuring consistently high data quality at the scale spanning hundreds to thousands of specimens.

Join this webinar to gain insights into spatial protein and RNA profiling for pancreatic and colorectal tumor microenvironment analysis.

Join Jonathan Nowak, MD, PhD, Molecular and GI Pathologist, Brigham and Women’s Hospital & Assistant Professor of Pathology, Harvard Medical School, for the live webinar on Tuesday, November 7, 2023, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Spatial Protein and RNA Profiling: Seeing the Unseen in the Tumor Microenvironment.

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Health

CoverRight® and Credit Union League of Connecticut (CULCT) Join Forces to Deliver Medicare Support to Over 1 Million Members

Leave a comment


With the average age of a credit union member being 47 years old, and approximately 60% of credit union members aged 65 or older, the partnership offers tailored Medicare guidance and support to approximately 600,000+ Medicare-eligible credit union members within Connecticut; as well as their family members who may be supporting them on health decisions.

CoverRight’s Medicare concierge platform simplifies the complex world of Medicare for those navigating the decision. This partnership will extend its valuable services to CULCT members.

With a focus on serving those primarily aged 60 and above, CoverRight® will provide personalized guidance, helping members navigate Medicare enrollment, understand their healthcare options, and optimize their coverage choices.

“As the trusted partner of the Credit Union League of Connecticut, we are committed to ensuring that their members receive the highest level of support and expertise in managing their healthcare needs,” said Richard Chan, Founder & CEO of CoverRight. “Our platform will empower credit union members to make well-informed decisions about Medicare coverage and health costs, providing peace of mind during a critical phase of their lives.”

This partnership between CoverRight and CULCT underscores the shared commitment to enhancing the well-being of credit union members as they navigate the complexities of Medicare. CoverRight’s platform will provide an easy way for credit unions to support their members and enhance their reputation as community-focused institutions.

“Our partnership with CoverRight exemplifies our commitment to providing solutions that lift all boats with a rising tide. Informed and empowered members make better financial decisions, and better financial decisions help credit unions grow. Connecticut’s credit unions and their members now have the resources and guidance needed to create a secure financial future into retirement,” added Bruce Adams, CULCT President and CEO.

For more information about CoverRight’s Medicare Concierge Platform and the partnership with the Credit Union League of Connecticut, please contact: [email protected]

Media Contact

Mayank Mittal, CoverRight, 1 347-695-3809, [email protected], www.coverright.com

SOURCE CoverRight

Health

Value and Utility vs. Challenges;, Upcoming Webinar Hosted by Xtalks

Leave a comment


The existing guidelines that do address the possibility of data collection fail to be specific enough, leaving the door open for interpretation. It is also important to note that these programs that anticipate more robust data collection (e.g., United States Treatment Use Protocol, United Kingdom Early Access to Medicines Program and France Early Access Program) also involve a more extensive approval process, including protocol and informed consent requirements.

Although continued and early access programs are not a substitute for data collection in clinical trials, they may provide supplemental data that address a variety of research questions that could be informative for multiple stakeholders, including regulatory bodies, payers, clinicians and patients. Data collection within these programs allows for generating RWD in typically broader patient populations compared to those analyzed in clinical trials. RWD generated in the pre-approval phase could augment primary clinical trial outcomes in submissions for market approval and are useful for informing future real-world use.

As the number of early access programs and the use of RWD to inform market access continue to grow, so will the benefits of collecting RWD in these programs.

Register for this webinar to learn more about the challenges and benefits of collecting RWD in continued and early access programs, along with opportunities to collect RWD that are scientifically robust, practical and ethical.

Join the following experts from the PPD clinical research business of Thermo Fisher Scientific: Emily Speas, Director, Project Management, Access Solutions, Peri- and Post-Approval Interventional Studies; Pedro Barroso Inácio, Manager, Regulatory Affairs; Martin Parkinson, Executive Director, Value and Access Consulting, Evidera Inc; and Grace Fattal (moderator), Director, Hematology Oncology, Project Delivery, for the live webinar on Tuesday, November 7, 2023, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Data Collection in Continued and Early Access Programs: Value and Utility vs. Challenges.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Health: Abortion

Communities In Schools and Whataburger Partner for Feeding Student Success Initiative

Leave a comment


“Whataburger’s investment in our National Office will help ensure that students continue to have access to a caring adult inside schools, connecting them to what they need when they need it. We’re proud the high-quality, evidence-based supports our national network provides created an opportunity for us to deepen Whataburger’s engagement with our national network,” said CIS President and CEO Rey Saldaña. “This historic donation represents more than just financial support; it symbolizes a shared vision for a brighter future for our students.”

Communities In Schools ensures every student, regardless of race, zip code, or socioeconomic background, has what they need to realize their potential in school and beyond. During the 2021-2022 school year, 99 percent of students enrolled in CIS programs remained in school through the end of the school year, with 97 percent of K-11 students being promoted to the next grade and 95 percent of seniors graduating or receiving a GED.

Whataburger celebrates the potential of all students and the power of education through its Feeding Student Success program, which focuses on the company’s charitable giving at the intersection of food insecurity and education through college resource rooms, scholarships, and community philanthropy. Since launching the program in 2020, Whataburger has given more than $5 million to support communities and students in need.

“Every child should have the chance to succeed in school and pursue their dreams,” said Whataburger President and CEO Ed Nelson. “Partnering with Communities In Schools is one of the best ways Whataburger can support students across our footprint, deliver Goodness 24/7 and create brighter futures in the communities that mean so much to us.”

ABOUT COMMUNITIES IN SCHOOLS
Communities In Schools® (CIS®) is a national organization that ensures every student, regardless of who they are, their ability, zip code or socioeconomic background, has what they need to realize their potential in school and beyond. Working directly inside more than 3,000 schools across the country, we connect students to caring adults and community resources that help them see, confront, and overcome the barriers that stand between them and a brighter future. Together, we build a powerful change movement made up of peers, students, and alumni committed to building an equitable path to education for future generations. Follow us for news @cisnational on Twitter or with the hashtag #AllinforKids.

ABOUT WHATABURGER
Whataburger is the hometown hamburger place that hasn’t compromised. We serve bold flavors and original recipes made to order, just like you like it, and pride ourselves on extraordinary hospitality and meaningful connections in our communities. That’s what’s led fans to Whataburger since Harmon Dobson served our first customer in 1950. Headquartered in San Antonio, we’ve stayed close to our roots while building sales of more than $3 billion annually across our 14-state footprint and over 950 locations. Even with our exceptional menu, we know that people make the difference at Whataburger. That’s why we’re a 2022 Top Workplaces Culture Excellence award winner. Want to become part of our orange spirit? Apply to become a Family Member (what we call our employees) at whataburger.com/careers. Just hungry for a great meal? Download our app on iOS or Android to order ahead. Shop Whataburger branded merchandise and selected sauces including our famous Fancy and Spicy Ketchup at WhataStore.com and find Whataburger original-recipe products in grocery stores. See our press kit for a list of locations, fun facts, milestones and other company information. 

Media Contact

Whitney Faison, Communities In Schools, 703-518-2575, [email protected], www.communitiesinschools.org/ 

SOURCE Communities In Schools

Health

Implandata Announces Appointment of New Members Dr. Adrienne Graves and Jan Willem de Cler to Join Board of Directors

Leave a comment


HANNOVER, Germany and SAN DIEGO, USA, October 24th, 2023 — Implandata Ophthalmic Products, an emerging ophthalmic health tech company based in Germany and USA, announced that Dr. Adrienne Graves and Mr. Jan Willem de Cler are appointed as new members of the company’s Board of Directors. Jan Willem de Cler will also take over responsibility as Chairman of the Board.

HANNOVER, Germany, Oct. 24, 2023 /PRNewswire-PRWeb/ — A visual scientist by training and a global industry leader in ophthalmology, Dr. Adrienne Graves brings extensive experience to Implandata. As the former CEO of Santen Inc., she successfully established a strong global presence, bringing multiple ophthalmic products through development to approval and commercialization and leading global teams through successful acquisitions and partnerships. Prior to Santen, she spent 9 years at Alcon, joining as Senior Scientist to establish Alcon’s first Retinal Electrophysiology Laboratory. She progressed through roles of increasing responsibility in research and development, including directing clinical development in multiple therapeutic areas and serving as Director of International Ophthalmology. Dr. Graves currently serves as a director on the boards of various ophthalmic pharmaceutical and health-tech companies. She serves on the Foundation Boards of the American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation (Emeritus), Retina Global, Himalayan Cataract Project, Foundation Fighting Blindness (FFB) and the RD (Retinal Degeneration) Fund. Dr. Graves also co-founded Glaucoma 360 and OWL (Ophthalmic World Leaders, formerly Ophthalmic Women Leaders).

Jan Willem de Cler, was Member of the DAX listed Carl Zeiss Meditec AG Management Board until September 2022, after which he became Executive in Residence and Senior Advisor to Private Equity and Non-Executive Director. Jan Willem studied Business Administration at Nijenrode University in the Netherlands and the University of Oregon, USA where he accomplished his MBA. Jan Willem then started his career at General Electric’s FMP and Corporate Audit Staff and spent the next 25 years in Health Care. He held different management positions at GE Medical Systems and became co-founder and Head of Sales and Marketing for GHX – Global Healthcare Exchange Europe, a successful startup that provides B2B solutions for supply chain efficiency between healthcare providers and suppliers. Jan Willem joined ZEISS Group in 2004 as Managing Director for the Benelux, and the French sales and service companies for all divisions, as well as serving as the President of France Chirurgie Instrumentation (FCI). From 2010 he led the Surgical Ophthalmology SBU at Carl Zeiss Meditec AG and built it up to its global leadership position. In 2018 he was appointed to the Board of Carl Zeiss Meditec AG as COO/CHRO/CSO and led M&A.

Implandata Ophthalmic Products, is an ophthalmic health-tech company dedicated to improving the lives of millions of people with glaucoma. Breakthroughs in bio-sensing, telemetry and data analytics led to the EYEMATE system. The CE-marked EYEMATE system is in use at leading eye centers in Europe. In the US market, EYEMATE has obtained the FDA “Breakthrough Device Designation” and IDE studies are in preparation.

Media Contact

Max Ostermeier, Implandata Ophthalmic Products, 49 51122042581, [email protected], https://www.implandata.com/

LinkedIn

SOURCE Implandata Ophthalmic Products

Health

Greenlight Guru Expands Market Leadership with Strong Momentum in Q3 2023

Leave a comment


In Q3, the company introduced the new MedTech Suite, a set of purpose-built solutions for medical device companies, designed to help them scale faster, become more efficient, and reduce risk throughout the product lifecycle. Greenlight Guru is also the only software provider in the MedTech industry that is actively leveraging the power of AI across its solutions. Greenlight Guru’s Risk Intelligence uses AI to help companies identify and predict the most relevant device hazards and patient harms with estimated probabilities and severities for their devices, based on real-world adverse event data. And the soon-to-be-released Digital Guru, currently in Beta testing, combines Greenlight Guru’s deep expertise in the medical device industry with the power of AI to create the only chat solution that is specifically trained and tailored for MedTech companies. Click here to join the Digital Guru waitlist.

The impact of Greenlight Guru’s software on its customers has led to it being named a G2 Award Leader in the QMS category for 20 consecutive quarters. In the recently released G2 Fall Grid Report, Greenlight Guru earned a total of 31 badges and was ranked #1 in the Medical QMS space for “Best Results,” “Best Relationship,” and “Most Implementable.” As one G2 Review states, “Greenlight is great because the platform has so many useful tools embedded in one place. You can have your design control matrix, risk matrix, customer feedback, nonconformances, CAPAs, and documents in one easy-to-view platform. Not only is the user interface clean and clear, but the staff are extremely knowledgeable and willing to help.”

“2023 has been a record-breaking year for Greenlight Guru, and that momentum has continued through Q3 as we are acquiring more large global customers at a rapid pace,” says David DeRam, CEO of Greenlight Guru. “We are proud that our MedTech Suite and AI-powered solutions are helping support the life-changing medical devices that are improving lives around the world.”

About Greenlight Guru
Greenlight Guru is the leading connected, cloud-based platform purpose-built for MedTech companies. The end-to-end solution streamlines product development, quality management, and clinical data management by integrating cross-functional teams, processes, and data throughout the entire product lifecycle. Greenlight Guru’s platform is used by organizations across the globe that are replacing their disjointed, legacy tools and solutions to bring life-changing products to people faster and with less risk. For more information, visit https://www.greenlight.guru.

Media Contact

PR at Greenlight Guru, Greenlight Guru, (317) 960-4220, [email protected], https://www.greenlight.guru/

SOURCE Greenlight Guru

Health: Addiction

RxBenefits Among Inc.’s Second Annual Power Partners Award Winners

Leave a comment


“Our team works hard to provide excellent pharmacy benefits to all our clients, including startups, and deliver solutions that optimize clinical, financial, and service experiences while enriching and protecting member health and safety,” RxBenefits CEO Wendy Barnes said. “We’re thrilled to be honored by Inc. Business Media for the way our core solutions bring value to startups, self-funded employers, and healthcare organizations navigating today’s benefits landscape. Congratulations to all the winners in the 2023 Power Partner Awards!”

Recently, RxBenefits launched several new products, including Optimize 340B, a comprehensive 340B management solution for healthcare entities, as well as enhanced versions of Protect and RxPharmacy Assurance, which are designed to reduce drug costs for patients and plans. The company has received several other awards for healthcare/pharmaceutical solutions and sales & customer service, including four consecutive Stevie Awards from 2020-2023.

“Trusted B2B partners provide guidance and expertise that founders rely on at various steps of their organization’s journey,” said Scott Omelianuk, editor-in-chief of Inc. Business Media. “Partners that possess a demonstrated ability to deliver quality support are at the core of entrepreneurship and help bring big ideas to life.”

To view the complete list Power Partner Award winners, go to: https://www.inc.com/power-partner-awards/2023

The November 2023 Issue of Inc. magazine is available online now at https://www.inc.com/magazine and will be on newsstands beginning October 31, 2023.

About RxBenefits
RxBenefits is a technology-enabled pharmacy benefits optimizer (PBO) with more than 800 pharmacy pricing, data, and clinical experts working together to deliver prescription benefit savings to employee benefit consultants and their self-funded clients. With more than 3 million members, RxBenefits brings market-leading purchasing power, independent clinical solutions, and high-touch service to its customers – ensuring that all plan sponsors, regardless of size, can provide an affordable and valuable pharmacy benefit plan to their employees. The company is headquartered in Birmingham, Ala. with a second office in Towson, Md. For more details, visit http://www.rxbenefits.com or follow the company on Facebook, Twitter, and LinkedIn.

About Inc. Business Media
The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community they need to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

Media Contact

Hollie Barnidge, Alloy, on behalf of RxBenefits, 855.300.8209, [email protected], rxbenefits.com

SOURCE RxBenefits



Health

Modern Meadow Wins 2023 EPA Green Chemistry Challenge Award

Leave a comment


Bio-FREED™ Fast Resource Efficient Enhancing Dyeing powered by Bio-Alloy™ delivers to the textile industry a greener one-step dyeing system that is a drop-in to replace the commonly used three-step dyeing process. Bio-FREED™ is a one-step continuous dyeing process that reduces water use by up to 95%, dye usage by up to 80% and decreases energy use by approximately 67%. Water reduction is achieved by eliminating two of the three water-intense steps, whereas the 80% dye usage reduction is achieved through precision delivery of the dyes to the fiber surface in the textile. Similarly, eliminating two energy-intensive steps decreases energy usage by approximately 67%. Bio-FREED™ treated textiles can also be pre-dyed or post-dyed further enabling additional environmental and supply chain benefits.

The Bio-FREED™ process is unique because it also increases production efficiency while improving polyester fibers’ resistance to color migration. Furthermore, It also offers a greater reduction in water and energy use relative to the ECOFAST Pure technology claims.

About Modern Meadow:
Modern Meadow is a purpose-driven company positioned at the intersection of material science and biology with a mission to be a catalyst for real-world impact on people and the planet. Our proprietary technology application platforms, Bio-F@rm™ (protein design and fermentation) & Bio-Alloy™ (protein and polymer tunable miscible blend), harness the unique properties of proteins to sustainably move the world away from petrochemical and animal-derived inputs without compromising on performance. These innovations can drop into any existing manufacturing infrastructures for immediate scalable adoption in the materials, beauty, biomedical, and other industries. Our close relationship with industry-leading development partners and production facilities allows companies partnering with Modern Meadow to feel confident knowing our high-quality products are 100% traceable from Lab-to-Brand™
For more information, visit http://www.modernmeadow.com

About EPA’s Green Chemistry Challenge Awards:
Since the inception of the awards more than a quarter century ago, EPA and the American Chemical Society, which co-sponsor the awards, have received more than 1,800 nominations and presented awards to 133 technologies that decrease hazardous chemicals and resources, reduce costs, protect public health, and spur economic growth. Winning technologies are responsible for annually reducing the use or generation of hundreds of millions of pounds of hazardous chemicals and saving billions of gallons of water and trillions of British thermal units (BTUs) in energy.

Media Contact

Arden Izzo, Modern Meadow, 716-713-7645, [email protected], www.modernmeadow.com

SOURCE Modern Meadow

Lifestyle: Self Help

Quantitative Bioanalysis of Antibody-Drug Conjugates by Mass Spectrometry, Upcoming Webinar Hosted by Xtalks

Leave a comment


In this free webinar, gain insights into the complexity, comprehensive strategy and regulatory considerations for bioanalysis in support of the development of drug-conjugated antibody (ADC). A case example will be presented for developing and validating a panel of liquid chromatography-mass spectrometry (LC-MS) pharmacokinetics (PK) assays: free drugs (payloads), drug-conjugated antibody (intact ADC) and total antibody. Attendees will learn bioanalytical strategies for ADC drug development and how to apply the PK assay results to inform on ADC stability and dose selection.

TORONTO, Oct. 24, 2023 /PRNewswire-PRWeb/ — Discover a groundbreaking webinar delving into bioanalytical complexity, strategy and regulatory considerations when developing ADC therapeutics with a focus on developing and validating liquid chromatography-mass spectrometry (LC-MS) pharmacokinetics (PK) assays.

Antibody-drug conjugates are a new and fast-growing class of targeted drugs consisting of “antibodies, cytotoxic drugs and linkers”. The antibody-drug conjugates are designed to increase the specificity and reduce the toxicity of cytotoxic drugs by utilizing antibodies to deliver the drug specifically to target cells (e.g., tumor cells) while avoiding toxicity in healthy cells. Design of a comprehensive bioanalytical strategy is critical to enable successful regulatory approval.

Understanding the PK profile of antibody-drug conjugates in pre-clinical and clinical studies is a regulatory expectation. Due to the complexity of ADC molecules, there are several analytes that need to be quantified to characterize ADC PK profiles, including free drugs (payloads), drug-conjugated antibodies (intact ADC) and total antibody. Amador Biosciences will share a case study demonstrating the successful development and validation of LC-MS methods for all three analytes.

Join this webinar to gain insights into bioanalytical considerations for ADC development and to learn how to develop and validate LC-MS PK assays which are used to generate data to inform stability and dose selection.

Join experts from Amador Bioscience, Meina Liang, Chief Technology Officer (CTO), President of Bioanalysis & Biomarkers; and Andrea Ngai, Associate Director, Bioanalysis & Biomarkers, for the live webinar on Wednesday, November 8, 2023, at 12pm EST (9am PST).

For more information, or to register for this event, visit Quantitative Bioanalysis of Antibody-Drug Conjugates by Mass Spectrometry.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks